| P50 | author | A Wesley Burks | Q88298853 |
| | Brian P. Vickery | Q56013921 |
| P2093 | author name string | J O'B Hourihane | |
| | A M Scurlock | |
| P2860 | cites work | Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 |
| | Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 |
| | Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract1 | Q28243179 |
| | Intestinal barrier function: molecular regulation and disease pathogenesis | Q28250081 |
| | Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas | Q28263136 |
| | Gastrointestinal dendritic cells promote Th2 skewing via OX40L | Q28509447 |
| | A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism | Q29614266 |
| | The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 | Q29619324 |
| | Rising prevalence of allergy to peanut in children: Data from 2 sequential cohorts | Q33185097 |
| | A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. | Q33858072 |
| | Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. | Q34014591 |
| | Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy | Q34548646 |
| | Oral tolerance and its relation to food hypersensitivities | Q34553986 |
| | Intestinal permeability in patients with adverse reactions to food | Q34569495 |
| | Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene | Q34579273 |
| | Complementary feeding: a commentary by the ESPGHAN Committee on Nutrition | Q34586513 |
| | IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. | Q34589849 |
| | Epidemiologic risks for food allergy | Q34592913 |
| | Immunologic changes in children with egg allergy ingesting extensively heated egg. | Q34598352 |
| | Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein | Q34602856 |
| | Successful oral tolerance induction in severe peanut allergy | Q34604676 |
| | Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction | Q66829364 |
| | The role of digestive enzymes in orally induced immune tolerance | Q69266934 |
| | HLA-DR-like antigens in the epithelium of the human small intestine | Q72150613 |
| | Stimulation by food proteins plays a critical role in the maturation of the immune system | Q73082163 |
| | Abrogation of oral tolerance by feeding encapsulated antigen | Q73501660 |
| | Life-threatening food allergy in a child treated with FK506 | Q73577001 |
| | Manufacturing and labeling issues for commercial products: relevance to food allergy | Q74481844 |
| | The impact of childhood food allergy on quality of life | Q77431896 |
| | Human milk-specific mucosal lymphocytes of the gastrointestinal tract display a TH2 cytokine profile | Q77902742 |
| | Peanut and tree nut allergy in children: role of peanut snacks in Israel? | Q79292636 |
| | Life-threatening anaphylaxis to kiwi fruit: protective sublingual allergen immunotherapy effect persists even after discontinuation | Q79381574 |
| | De novo food allergy after intestinal transplantation: a report of three cases | Q79960673 |
| | Tacrolimus immunosuppression - an association with asymptomatic eosinophilia and elevated total and specific IgE levels | Q80119175 |
| | A protocol for oral desensitization in children with IgE-mediated cow's milk allergy | Q80413023 |
| | Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract | Q81454014 |
| | Rush oral immunotherapy in children with persistent cow's milk allergy | Q81583734 |
| | Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation | Q81617509 |
| | Inhibition of Experimental Drug Allergy by Prior Feeding of the Sensitizing Agent | Q82174999 |
| | The impact of food allergy on the daily activities of children and their families | Q83098423 |
| | Profiling families enrolled in food allergy immunotherapy studies | Q84464334 |
| | Interferon-gamma and pulmonary macrophages contribute to the mechanisms underlying prolonged airway hyperresponsiveness | Q84877305 |
| | Interpretation of commercial food ingredient labels by parents of food-allergic children | Q34683900 |
| | Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. | Q35591418 |
| | Multicenter study of emergency department visits for food allergies | Q35651430 |
| | Mechanisms of immunotherapy. | Q35811876 |
| | Development of a questionnaire to measure quality of life in families with a child with food allergy | Q35944895 |
| | The development of food allergy after liver transplantation | Q36047458 |
| | Oral tolerance and allergic responses to food proteins | Q36466994 |
| | Food allergy QoL questionnaire for children aged 0-12 years: content, construct, and cross-cultural validity | Q37147227 |
| | A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy | Q37150568 |
| | Filaggrin in atopic dermatitis. | Q37261751 |
| | Clinical efficacy and immune regulation with peanut oral immunotherapy | Q37301616 |
| | Safety of a peanut oral immunotherapy protocol in children with peanut allergy | Q37316978 |
| | Open-label maintenance after milk oral immunotherapy for IgE-mediated cow's milk allergy | Q37336159 |
| | Impairing oral tolerance promotes allergy and anaphylaxis: a new murine food allergy model | Q37453377 |
| | Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells | Q42766901 |
| | Adverse reactions during peanut oral immunotherapy home dosing | Q42951847 |
| | Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy | Q43225422 |
| | Severe anaphylaxis to kiwi fruit: Immunologic changes related to successful sublingual allergen immunotherapy | Q44265145 |
| | Oral desensitizing treatment in food allergy: clinical and immunological results | Q44299630 |
| | Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model | Q44355416 |
| | Persistent protective effect of heat-killed Escherichia coli producing "engineered," recombinant peanut proteins in a murine model of peanut allergy | Q44504353 |
| | Epicutaneous exposure to protein antigen and food allergy | Q44545289 |
| | The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy | Q45215097 |
| | Food Allergy Herbal Formula-2 silences peanut-induced anaphylaxis for a prolonged posttreatment period via IFN-gamma-producing CD8+ T cells | Q46128144 |
| | Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity | Q46675736 |
| | Clinical features of acute allergic reactions to peanut and tree nuts in children | Q47891189 |
| | The impact of government advice to pregnant mothers regarding peanut avoidance on the prevalence of peanut allergy in United Kingdom children at school entry | Q50458691 |
| | Egg oral immunotherapy in nonanaphylactic children with egg allergy. | Q50702311 |
| | Impact of peanut allergy on quality of life, stress and anxiety in the family. | Q50765092 |
| | Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy. | Q51811667 |
| | Solid food introduction in relation to eczema: results from a four-year prospective birth cohort study. | Q51905377 |
| | FK506 increases permeability in rat intestine by inhibiting mitochondrial function. | Q52507776 |
| | Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. | Q52558967 |
| | Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization. | Q52564817 |
| | The allergic sensitization in infants with atopic eczema from different countries. | Q53201777 |
| | Induction of tolerance after establishment of peanut allergy by the food allergy herbal formula-2 is associated with up-regulation of interferon-gamma. | Q53551457 |
| | Further fatalities caused by anaphylactic reactions to food, 2001-2006. | Q55043255 |
| | Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey | Q55921151 |
| | The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans | Q57221649 |
| | Specific oral tolerance induction in children with very severe cow's milk–induced reactions | Q57243160 |
| | Household peanut consumption as a risk factor for the development of peanut allergy | Q57414792 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | food allergy | Q769815 |
| P304 | page(s) | 345-354 | |
| P577 | publication date | 2010-05-26 | |
| P1433 | published in | Mucosal Immunology | Q15817743 |
| P1476 | title | Pediatric food allergy and mucosal tolerance | |
| P478 | volume | 3 | |